Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II)
Clinical trial NCT04928222 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04928222
- Sponsor
- SkinJect, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-24
- Primary completion
- 2023-12-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.